Back to Archived News
Former Acting Chief Counsel of the FDA, Jeffrey M. Senger, Joins Sidley Austin LLP in Washington, DC
Monday, August 02, 2010
Washington, D.C. - Sidley Austin LLP announced today that Jeffrey M. Senger, former Acting Chief Counsel and Deputy Chief Counsel of the Food and Drug Administration, has joined Sidley as a partner in the global food, drug and medical device regulatory practice. He will be based
in the firm’s Washington, D.C. office and will focus on a broad array of enforcement, compliance and regulatory matters.“Jeff brings a wealth of insight to Sidley's FDA practices from his experience at both FDA and the Department of Justice. He is one of only a handful of highly seasoned lawyers who understand the increasingly complex interrelationships between those two executive agencies,” said Coleen Klasmeier, global coordinator of the firm’s global food, drug and medical device regulatory practice and a former Staff Attorney/Special Assistant to the Chief Counsel of FDA.
Mr. Senger previously served as Senior Counsel in the Office of the Associate Attorney General at the United States Department of Justice, where he assisted in overseeing the work of more than 2000 lawyers, including specific responsibility for the office that provided counsel and legal representation to the FDA. Throughout his 17 years at the Justice Department, including an appointment as a Special Assistant United States Attorney, Mr. Senger served as lead counsel in many civil and criminal trials before juries and judges in federal and state courts, and he argued cases in the U.S. Circuit Courts of Appeals. Mr. Senger graduated with honors from Harvard College and Harvard Law School, and he began his career as a law clerk for a federal judge.
“An internationally recognized figure, Jeff has an internal understanding of the FDA combined with a handle on the complex regulatory and enforcement environments in which we work and will be a tremendous asset to us as we continue to navigate life science issues on a global scale,” said Raymond A. Bonner, a member of Sidley’s Executive Committee and global coordinator of the firm’s food, drug and medical device compliance and enforcement practice.
“Sidley is the leading global practice, and the first with a comprehensive food and drug regulatory practice in China, making it the go-to firm for life science companies dealing with challenging legal and regulatory issues,” said Mr. Senger. “The firm has the commitment to this industry and the global presence that are so critical to long-term success.”
Sidley has an internationally recognized food and drug practice, representing major pharmaceutical, biological, medical device and food clients all over the world on matters relating to the development, manufacture and marketing of products regulated by the FDA, the European Commission, the European Medicines Agency, the P.R.C. regulatory authorities and other related government authorities.
Sidley Austin LLP is one of the world’s largest full-service law firms, with approximately 1700 lawyers practicing in 17 U.S. and international cities, including Beijing, Brussels, Frankfurt, Geneva, Hong Kong, London, Shanghai, Singapore, Sydney and Tokyo. Sidley is recognized for service and responsiveness—BTI, a Boston-based research and consulting firm, has named Sidley as one of only two firms to have been in the top ten of the BTI Client Service rankings every year since the inception of those rankings in 2001, and as number one in three of those years.
For purposes of the New York State Bar rules, this press release may be considered Attorney Advertising and the headquarters of the firm are Sidley Austin LLP 787 Seventh Avenue, New York, NY 10019, 212.839.5300 and Sidley Austin LLP One South Dearborn, Chicago, IL 60603, 312.853.7000. Prior results described herein do not guarantee a similar outcome.
Back to Archived News
